FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

19380211000001102: Doublebase Dayleve gel (Dermal Laboratories Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 24-Aug 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
65352101000001119 Doublebase Dayleve gel (Dermal Laboratories Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
65352201000001114 Doublebase Dayleve gel (Dermal Laboratories Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Doublebase Dayleve gel (Dermal Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Doublebase Dayleve gel (Dermal Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Doublebase Dayleve gel (Dermal Laboratories Ltd) Is a Isopropyl myristate 15% / Liquid paraffin 15% gel true Inferred relationship Existential restriction modifier
Doublebase Dayleve gel (Dermal Laboratories Ltd) Has active ingredient Mineral oil true Inferred relationship Existential restriction modifier
Doublebase Dayleve gel (Dermal Laboratories Ltd) Has active ingredient Isopropyl myristate true Inferred relationship Existential restriction modifier
Doublebase Dayleve gel (Dermal Laboratories Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Doublebase Dayleve gel (Dermal Laboratories Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Doublebase Dayleve gel (Dermal Laboratories Ltd) Has specific active ingredient Mineral oil true Inferred relationship Existential restriction modifier
Doublebase Dayleve gel (Dermal Laboratories Ltd) Has specific active ingredient Isopropyl myristate true Inferred relationship Existential restriction modifier
Doublebase Dayleve gel (Dermal Laboratories Ltd) Has dispensed dose form Gel true Inferred relationship Existential restriction modifier
Doublebase Dayleve gel (Dermal Laboratories Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Doublebase Dayleve gel (Dermal Laboratories Ltd) Is a Doublebase true Inferred relationship Existential restriction modifier
Doublebase Dayleve gel (Dermal Laboratories Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Doublebase Dayleve gel (Dermal Laboratories Ltd) Has manufactured dose form Gel false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Doublebase Dayleve gel (Dermal Laboratories Ltd) 100 gram Has AMP True Doublebase Dayleve gel (Dermal Laboratories Ltd) Inferred relationship Existential restriction modifier
Doublebase Dayleve gel (Dermal Laboratories Ltd) 500 gram Has AMP True Doublebase Dayleve gel (Dermal Laboratories Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start